Our expert, Dr. Krishna Mohan Boopathy Vijayaraghavan, discussed the most concerning query regarding men's health and Urology niche. Medbound Times had an insightful conversation with him.
Dr. Krishna Mohan Boopathy Vijayaraghavan is a urologist and men’s health specialist. He is an assistant professor at PSG Hospital, Coimbatore,Tamil Nadu, India.
The medical speciality of urology focuses on the diagnosis and treatment of conditions affecting the male and female urinary tract systems, as well as the male reproductive system. Like any medical specialty, urology develops with evidence over time as a result of continual study, clinical trials, and the expansion of scientific understanding.
Most common problem men face after the age of 50 is BPH (benign prostatic hyperplasia). It is a disorder in which the prostate gland develops to a bigger size. It is a prevalent ailment that affects almost all males as they age, especially those over the age of 50.
The etiology of prostate enlargement is uncertain, however, it is thought to be related to hormonal changes that occur as men age. As men get older, the balance of hormones in their bodies changes, which may cause the prostate gland to enlarge.
Evidence-based medicine, which entails using the best available data from well-conducted clinical studies to improve medical decisions and practices, is frequently the driving force behind advancements in urology. New technologies, drugs, surgical techniques, and treatment philosophies can all be part of these breakthroughs.
Dr. Krishna Mohan Boopathy Vijayaraghavan, some examples of recent advances in urology include:
New surgical methods: Laparoscopy and robotic-assisted surgery are two minimally invasive surgical methods that have changed urological operations by enabling smaller incisions, less pain, faster recovery, and better results.
Precision medicine: Developments in molecular biology and genetics have produced individualized methods for urological disease diagnosis and therapy. It is possible to pinpoint specific mutations or biomarkers that affect treatment choices with the aid of genetic testing and tailored medicines.
Immunotherapy for bladder cancer: Immune checkpoint inhibitors like pembrolizumab and atezolizumab, which boost the body's defenses against cancer cells, have shown encouraging outcomes in the treatment of advanced bladder cancer.
Diagnosis and Treatment: Enhanced prostate cancer detection and characterization thanks to imaging technologies like multiparametric magnetic resonance imaging (MRI) have allowed for more precise diagnosis and treatment planning.
Treatments for benign prostatic hyperplasia (BPH) that need little to no surgery. Modern treatments for BPH reduce the need for invasive operations by offering alternatives to conventional surgery, such as UROLIFT, HIFU (High-intensity focused ultrasound), transurethral microwave therapy (TUMT) and prostate artery embolization (PAE).
According to Dr. Krishna Mohan Boopathy Vijayaraghavan, urology is a quickly developing discipline, and new developments are constantly occurring. You can get the most up-to-date, evidence-based knowledge on urological diseases and treatments by speaking with a urologist or by keeping up with relevant medical literature and reliable sources.
